Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Carbonate in CKD with Normophosphatemia
NCT03550534Completed
- Sponsor
- Universitas Indonesia
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic kidney disease (CKD) comparing Calcium Carbonate with Placebo (2 arms). Primary endpoint: Serum Fibroblast Growth Factor 23 at 12 weeks. Started Nov 2015; status: completed.
02
Drugs
calcium carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03550534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550534.